Subbarao Uppaluri V - 18 Jun 2026 Form 4 Insider Report for OPKO HEALTH, INC. (OPK)

Reporting relationship: Director
Issuer ticker: OPK
Reported as of: 18 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Jun 2026, 17:33:26 UTC
Prior SEC filing: 20 Mar 2026
Source filing: View source filing
Reporting owner signature: Steven D. Rubin, Attorney-in-Fact

Key filing fact

Subbarao Uppaluri V filed Form 4 for OPKO HEALTH, INC. (OPK) on 22 Jun 2026.

Key facts

This page summarizes Subbarao Uppaluri V's Form 4 filing for OPKO HEALTH, INC. (OPK).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 22 Jun 2026, 17:33.

Change

Previous filing in this sequence was filed on 20 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001389406 Primary reporting owner

UPPALURI SUBBARAO V

Relationship: Director
Address: OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI
Signature: Steven D. Rubin, Attorney-in-Fact
Signature date: 22 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OPK transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +80,000
Change %
Price: $0.000000^*
Shares after: 80,000
Date: 18 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 80,000
Exercise price: $1.42
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On June 18, 2026, the Issuer canceled the grant of 50,000 options previously made to the Reporting Person and, as a part of the Issuer's standard director compensation, granted the Reporting Person an option to purchase 30,000 shares, and reissued an option to purchase 50,000 shares of the Issuer's common stock.